| Treatment with sitagliptin or metformin does not increase body weight despitepredicted reductions in urinary glucose excretion. | J Diabetes Sci Technol | 2009 Jan | 20046651 |
| The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells. | Mol Nutr Food Res | 2009 Feb | 19035551 |
| Type 2 diabetes mellitus with pancreatic beta cell dysfunction in 3 horsesconfirmed with minimal model analysis. | Equine Vet J | 2009 Dec | 20383993 |
| Insulin sensitizing actions of fenugreek seed polyphenols, quercetin & metformin in a rat model. | Indian J Med Res | 2009 Apr | 19535835 |
| Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulinresistance induced by high-fat feeding of mice. | Diabetes | 2008 Nov | 18728234 |
| Attenuation of hypertension development by scavenging methylglyoxal infructose-treated rats. | J Hypertens | 2008 Apr | 18327087 |
| Effect of fast-food Mediterranean-type diet on human plasma oxidation. | J Med Food | 2007 Sep | 17887946 |
| [Exenatide--an incretin-mimetic agent for the treatment of type 2 diabetesmellitus]. | Dtsch Med Wochenschr | 2007 Mar 16 | 17342635 |
| Is exenatide improving the treatment of type 2 diabetes? Analysis of theindividual clinical trials with exenatide. | Rev Recent Clin Trials | 2007 Jan | 18473991 |
| Diffusion into use of exenatide for glucose control in diabetes mellitus: aretrospective cohort study of a new therapy. | Clin Ther | 2007 Aug | 17919559 |